Re-ALK is a medical management tool designed to support the treatment of ALK-rearranged Non-Small Cell Lung Cancer. The app facilitates communication between patients and doctors while providing clinical resources and treatment tracking tools.
Overview · Full Intel report in progress
The App DNA
What makes this app unique?
For Patients diagnosed with ALK-rearranged Non-Small Cell Lung Cancer and their treating physicians.
What does it look like?
Key features
Provides educational materials for patients and clinical decision-making algorithms for doctors across various treatment lines.
Allows patients to log adverse events and enables doctors to monitor these reports over time.
Enables patients to set personalized reminders to improve medication adherence.
Offers a platform for direct communication and discussion between patients and medical professionals.
How much does it cost?
Velocity
Who built it?
Sowlutions
5 apps tracked · Medical
Ur My Type - Dating. Friends.
Fabriq: Stay in Touch
POPS Logger
POPS AdminUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Re-ALK
How's the Medical market?
The rivals identified
The Analyst's Read
Key takeaways for Re-ALK
Where is it heading?
Bottom line
The app functions as a dual-interface management platform intended to improve treatment adherence and clinical monitoring for a specific oncology patient population.
Report last updated